fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Maximising bang for your buck in IBD

Written by | 11 Apr 2017

Dr Peter Irving (London) talks about one of the hot topics for the future -Maximising the bang for your buck in IBD. He highlights the possible benefits of treating… read more.

BSH 2017: How I treat molecular high-risk myeloma – what can we do, what should we do?

Written by | 6 Apr 2017

High-risk multiple myeloma (MM) continues to pose a challenge to haematologists both in terms of diagnostics and therapy. Opening the UK Myeloma Forum at the 2017 BSH annual… read more.

BSH 2017: Are we ready to use minimum residual disease to direct therapy?

Written by | 4 Apr 2017

Studies show that MM patients who achieve minimal residual disease on treatment have longer PFS and OS than those who do not…

New compounds in the treatment of IBD (ECCO 2017)

Written by | 17 Mar 2017

Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.

Post-surgical pain scores improve as analgesic opioid use falls

Written by | 27 Feb 2017

Researchers who conducted a retrospective analysis of data from over 100,000 surgical cases in one university health system have reported that patients’ pain scores improved when physicians administered… read more.

Strong cannabis linked to dependency

Written by | 31 Jan 2017

New data presented at this year’s International Early Psychosis Association (IEPA) meeting in Milan, Italy (20-22 October) adds to accumulating evidence that high-potency cannabis in associated with an… read more.

Cancer survival worse in RA patients

Written by | 19 Aug 2016

Survival was more than 2 years shorter in breast, prostate cancers.  Patients with rheumatoid arthritis (RA) had a 40% to 50% increased mortality risk if they developed breast… read more.

Less painkilling medication with breast-cancer surgery after opiate-free anesthesia

Written by | 12 Aug 2016

New research presented at Euroanaesthesia 2016 (London 27-30 May) shows that patients undergoing breast cancer surgery need less painkilling medication post-surgery if they have anaesthesia that is free… read more.

EHA 2016: Consolidation and maintenance therapy for multiple myeloma: is it the new standard? Professor Paul Richardson (Harvard Medical School, Boston, USA) and Professor Maria-Victoria Mateos (Salamanca, Spain) discuss the meta-analysis of OS in myeloma with maintenance therapy presented at ASCO and EHA this year, along with strategies for continuous therapies

Written by | 3 Aug 2016

Consolidation and maintenance therapy for multiple myeloma: is it the new standard?   Professor Antonio Palumbo (University of Turin, Italy) and Professor Paul Richardson (Harvard Medical School, Boston,… read more.

EHA 2016: Pathophysiology and diagnosis of multiple myeloma bone disease. The chair of this year’s EHA educational session on myeloma, Professor Roman Hajek (University of Ostrava, Czech Republic), discusses highlights from the session.

Written by | 2 Aug 2016

Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.

EHA 2016: Pathophysiology and diagnosis of multiple myeloma bone disease. The chair of this year's EHA educational session on myeloma, Professor Roman Hajek (University of Ostrava, Czech Republic), discusses highlights from the session.

Written by | 2 Aug 2016

Pathophysiology and diagnosis of multiple myeloma bone disease Evangelos Terpos, University of Athens School of Medicine, Greece Osteolytic bone disease is the most common complication of MM and… read more.

Study supports use of aspirin after transient ischemic attack (TIA)

Written by | 13 Jul 2016

by Bruce Sylvester: Following a transient ischemic attack (TIA), quick aspirin treatment can significantly reduce the risk of a major stroke in the next few days, researchers reported… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.